Empaflo M 12.5/1000mg Tablets 30’s

Empaflo M 12.5/1000 mg Tablets are a fixed-dose combination of Empagliflozin (12.5 mg), a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and Metformin (1000 mg), a biguanide. This dual therapy is indicated for the management of type 2 diabetes mellitus in adults, providing complementary mechanisms of action to improve glycemic control:

• Empagliflozin lowers blood glucose by reducing renal glucose reabsorption and increasing urinary glucose excretion.
• Metformin decreases hepatic glucose production, improves insulin sensitivity, and enhances peripheral glucose uptake.

Together, they help achieve better blood sugar control, reduce cardiovascular risk, and support long-term diabetes management.